These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6768058)

  • 41. [A case of paternity exclusion based on Rh-Hr factors].
    AMBROSIO J
    Dtsch Z Gesamte Gerichtl Med; 1953; 42(1):42-3. PubMed ID: 13083301
    [No Abstract]   [Full Text] [Related]  

  • 42. [Rh-Hr factors and exclusion of paternity].
    TORTORA M
    Arch Ostet Ginecol; 1955; 60(4):217-20. PubMed ID: 13283748
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of the GPT system in serological and hereditary expert testimony].
    Berg K; Hamm U; Schwarzfischer F; Wischerath H
    Med Lab (Stuttg); 1974 Nov; 27(11):283-5. PubMed ID: 4437455
    [No Abstract]   [Full Text] [Related]  

  • 44. [Distribution of the Rh factors in the German population, and its value for determination of paternity by exclusion].
    NAGEL V; HOFFMANN M; PROKOP O
    Acta Genet Med Gemellol (Roma); 1953 May; 2(2):126-38. PubMed ID: 13057538
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of the characteristics of the MNSs system in expertise of possible mix-up of children (case from practice)].
    Tumanov AK; Masis TM; Iudina GS; Il'ina EA
    Sud Med Ekspert; 1972; 15(3):42-4. PubMed ID: 4638247
    [No Abstract]   [Full Text] [Related]  

  • 46. [Objectivation of the biostatistic efficiency of the heredity system in blood group expertises].
    Hummel K
    Beitr Gerichtl Med; 1976; 34():137-9. PubMed ID: 971223
    [No Abstract]   [Full Text] [Related]  

  • 47. [Distribution of Rh factor E/e in Schleswig-Holstein and its application in paternity exclusion processes].
    NAGEL V
    Z Hyg Infektionskr; 1955; 140(6):582-6. PubMed ID: 14397573
    [No Abstract]   [Full Text] [Related]  

  • 48. [Paternity from the obstetrical viewpoint - expert testimony].
    Lindner E; Nevrla F
    Cesk Gynekol; 1975 Dec; 40(10):699-700. PubMed ID: 1204014
    [No Abstract]   [Full Text] [Related]  

  • 49. Transferrin system in paternity cases. An immunological verification test for heterozygosity.
    Seppälä M; Ruoslahti E; Seppälä IJ
    Ann Med Exp Biol Fenn; 1967; 45(1):14-5. PubMed ID: 6070455
    [No Abstract]   [Full Text] [Related]  

  • 50. [Positive paternity determination with the Essen-Möller seologic biostatic method].
    Gross H; Gross HG
    Med Welt; 1969 Aug; 33():1776-8. PubMed ID: 5357976
    [No Abstract]   [Full Text] [Related]  

  • 51. [Exclusion of paternity by determination of Rh subgroups].
    MANZ R
    Dtsch Z Gesamte Gerichtl Med; 1952; 41(1):57-60. PubMed ID: 12979874
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sociological studies on paternity expert testimony in involved persons].
    Klose I
    Beitr Gerichtl Med; 1974; 32():167-70. PubMed ID: 4468779
    [No Abstract]   [Full Text] [Related]  

  • 53. [The practical significance of the Essen-Moeller method and the "Rh combination calculation" for serological paternity expert testimony with use of the ABO, MN, Rh, Kell and P systems. III. The efficacy of the method in cases with two or more men, empirically determined].
    HUMMEL K; SCHMIDTKE I
    Z Immun exp ther; 1959 Aug; 118():108-20. PubMed ID: 14405353
    [No Abstract]   [Full Text] [Related]  

  • 54. [Applications of RHD zygosity test through polymerase chain reaction for prediction of fetus Rh D-positive phenotype].
    Shao CP
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):223-5. PubMed ID: 12885370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Twenty seven years of expert opinions in immunohaematology in Plzen (author's transl)].
    Kulich V; Pribilová A; Bufková D
    Cas Lek Cesk; 1981 Jan; 120(3-4):92-5. PubMed ID: 7214434
    [No Abstract]   [Full Text] [Related]  

  • 56. [Genetic aspects of evidential value of Rh-subgroups].
    WICHMAN D
    Z Immun exp ther; 1954 Jun; 111(2):121-4. PubMed ID: 13179740
    [No Abstract]   [Full Text] [Related]  

  • 57. Heterozygosity and extra-pair paternity: biased tests result from the use of shared markers.
    Wetzel DP; Westneat DF
    Mol Ecol; 2009 May; 18(9):2010-21. PubMed ID: 19302363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Verification of private paternity analysis at the Institutes of Legal Medicine in Greifswald, Jena, and Kiel].
    von Wurmb-Schwark N; Simeoni E; Poetsch M; Banaschak S; Mályusz V; Schwark T
    Arch Kriminol; 2008; 222(5-6):152-61. PubMed ID: 19216365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Forensic evaluation of Rh-subgroups].
    HALLERMANN W; NAGEL V
    Acta Genet Med Gemellol (Roma); 1954 May; 3(2):163-9. PubMed ID: 13180189
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evolution of Supreme Court settlements relating to DNA evidence in paternity investigations].
    Berent J; Jacewicz R; Szram S
    Arch Med Sadowej Kryminol; 2002; 52(3):195-204. PubMed ID: 14669690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.